Detalles de la búsqueda
1.
Vaccinology in the post-COVID-19 era.
Proc Natl Acad Sci U S A
; 118(3)2021 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33431690
2.
TMQuery: a database of precomputed template modeling scores for assessment of protein structural similarity.
Bioinformatics
; 38(7): 2062-2063, 2022 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35104317
3.
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.
Immunity
; 41(6): 909-18, 2014 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25526306
4.
Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.
PLoS Pathog
; 16(4): e1008531, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32343743
5.
Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency.
J Virol
; 94(4)2020 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31776278
6.
ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.
PLoS Pathog
; 15(12): e1008121, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31794588
7.
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
PLoS Med
; 17(2): e1003038, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32092060
8.
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.
J Virol
; 93(3)2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30429340
9.
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.
J Virol
; 93(3)2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30429343
10.
A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection.
J Infect Dis
; 220(6): 990-1000, 2019 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31058977
11.
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates.
J Virol
; 92(8)2018 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29437967
12.
Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.
PLoS Pathog
; 13(2): e1006182, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28235027
13.
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
J Virol
; 91(9)2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28179536
14.
Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition.
J Immunol
; 197(7): 2726-37, 2016 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27591322
15.
Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial.
J Infect Dis
; 215(8): 1255-1263, 2017 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28329190
16.
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.
J Virol
; 90(8): 4133-4149, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26865719
17.
Broad neutralization coverage of HIV by multiple highly potent antibodies.
Nature
; 477(7365): 466-70, 2011 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-21849977
18.
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9.
Nature
; 480(7377): 336-43, 2011 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-22113616
19.
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates.
J Virol
; 89(16): 8525-39, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26041302
20.
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates.
J Virol
; 89(16): 8643-50, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26018159